Avricore Health (AVCRF) Income towards Parent Company (2009 - 2025)

Avricore Health has disclosed Income towards Parent Company across 16 years of filings, most recently posting -$35788.2 for Q3 2025.

• In Q3 2025, Income towards Parent Company fell 111.23% year-over-year to -$35788.2; the TTM figure through Dec 2025 stood at $174196.7 (down 81.66% YoY), while the FY2025 annual figure was $179230.2, up 136.68% from the prior year.
• Income towards Parent Company retreated to -$35788.2 in Q3 2025, from -$31914.1 in the prior quarter.
• Over the last five years, Income towards Parent Company for AVCRF reached as high as $2.4 million in Q4 2021 and fell as low as -$444623.1 in Q3 2022.
• The 5-year median for Income towards Parent Company is $170830.3 (2023), against an average of $273934.4.
• Annual changes were most pronounced in 2022 — Income towards Parent Company surged 91317955.07% — and 2025, when it tumbled 111.77%.
• A 5-year view of Income towards Parent Company shows it stood at $2.4 million in 2021, then sank by 42.43% to $1.4 million in 2022, then slumped by 73.71% to $369002.7 in 2023, then dropped by 13.62% to $318731.6 in 2024, then plunged by 111.23% to -$35788.2 in 2025.
• According to Business Quant data, Income towards Parent Company over the past three periods registered -$35788.2, -$31914.1, and $241899.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.